1. Modeling and biological evaluation of pegmolesatide, a novel and potent erythropoiesis-stimulating agent.
- Author
-
Zhou, En-Jia, Lang, Xu-Li, Yang, Min-Jian, Sun, Han-Yu, Hao, Meng-yao, Jin, Jing, Wang, Bao-Lian, Li, Ai-Jun, and Wang, Xiao-Jian
- Subjects
ANEMIA ,HEMATOPOIETIC agents ,IN vitro studies ,SAFETY ,BIOLOGICAL models ,ERYTHROPOIETIN ,ERYTHROPOIESIS ,BIOLOGICAL products ,DRUG delivery systems ,DESCRIPTIVE statistics ,POLYETHYLENE glycol ,DRUG efficacy ,MOLECULAR structure ,RECOMBINANT proteins ,PHARMACODYNAMICS - Abstract
Pegmolesatide, a synthetic, polyethylene-glycolylated, peptide-based erythropoiesis-stimulating agent (ESA), has been recently approved in China. Pegmolesatide is derived from the structure of endogenous erythropoietin (EPO), a natural product in mammals. This study compared the in vitro effects and selectivity of pegmolesatide to those of recombinant EPO and carbamylated EPO (CEPO) through computer-aided analyses and biological tests. The findings indicate that pegmolesatide exhibited the same stimulating effect on erythropoiesis as EPO with fewer side effects than EPO and CEPO. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF